GHK

The Uncomplexed Tripeptide

GHK is the tripeptide glycyl-L-histidyl-L-lysine, a three-residue sequence with a molecular weight of roughly 340 daltons. It is one of the smallest bioactive peptides characterized in human biology and occurs naturally in plasma, saliva, and urine. Biochemist Loren Pickart first identified the sequence in 1973 while investigating a plasma factor that appeared to rejuvenate aged hepatocyte cultures — a factor whose activity declined measurably with donor age. GHK circulates at roughly 200 ng/mL in young adults and drops to near 80 ng/mL by the seventh decade of life.

Most of the current clinical and cosmetic literature focuses on the copper-bound form (GHK-Cu), but the uncomplexed tripeptide has its own pre-copper research history and distinct signaling profile worth understanding on its own terms.

Structure and Copper Affinity

GHK's defining chemical property is its unusually high affinity for copper(II) ions. The histidine imidazole nitrogen, the glycine amino terminus, and the peptide-bond nitrogen between glycine and histidine coordinate copper in a stable 1:1 square-planar chelate. Under physiological conditions, any free GHK encountering bioavailable copper rapidly forms the complex. This means that pure uncomplexed GHK in vivo is largely a transient state — the peptide readily scavenges copper from albumin and ceruloplasmin to equilibrate into GHK-Cu.

This matters for research design: experiments that label their test article "GHK" but use cell culture media containing trace copper are effectively studying GHK-Cu. Teasing apart the biological effects of the copper-free peptide requires strict copper-chelated conditions.

Pre-Copper Research

Before the copper complex dominated the literature, GHK itself was studied primarily for three effects:

• Hepatocyte growth support. Pickart's original 1973 work described GHK as a liver cell growth factor whose activity was later clarified to depend heavily on its copper-binding capacity.
• Fibroblast signaling. Uncomplexed GHK binds specific receptors on dermal fibroblasts and modulates gene expression related to extracellular matrix production, including collagen I, collagen III, and decorin.
• Macrophage recruitment. GHK has been shown to act as a chemoattractant for macrophages and to modulate their activation state during wound healing.

A 2010 transcriptomic analysis by Campbell and colleagues reported that GHK at 1 μM altered expression of roughly 4,000 human genes, though the cell-culture conditions used in that study did not rigorously exclude trace copper — a caveat relevant to interpreting how much of the effect is intrinsic to the uncomplexed peptide.

Topical and Injectable Context

Uncomplexed GHK is used less often in skincare than its copper-bound analogue. The blue-green copper color that makes GHK-Cu formulations visually distinctive is absent from pure GHK, which is also more prone to oxidative degradation in aqueous formulation. Injectable research protocols occasionally use pure GHK on the assumption that endogenous copper will form the complex in vivo — an assumption reasonable in principle but not rigorously characterized in pharmacokinetic studies.

For a categorical overview, see our copper peptide complex reference, which covers GHK-Cu and related chelated peptides as a class.

Regulatory and Practical Status

GHK is not an FDA-approved therapeutic in any form. Topical cosmetic use is long-standing and uncontroversial — decades of formulation history without significant adverse signals. Injectable GHK is available only through research-chemical channels and compounding pharmacies with the usual caveats about purity, identity, and endotoxin characterization.

Side effects reported with topical use are limited to occasional skin irritation and contact sensitivity. Systematic safety data for injectable uncomplexed GHK is effectively absent, which is the key gap to flag before extrapolating topical safety to parenteral use.

Bottom Line

GHK without copper is chemically interesting and biologically active in vitro, but the line between "GHK" and "GHK-Cu" in the published literature is blurrier than most references admit. For anyone evaluating the tripeptide for its own sake, the relevant question is whether the available data actually excluded copper — and in most cases the answer is that it did not. Our GHK-Cu deep dive covers the broader research arc.